The number of meningitis cases linked to an outbreak in Kent has risen to 27, according to the UK Health Security Agency, as authorities continue efforts to contain the spread.
Seven new cases have been confirmed, with 15 laboratory-verified infections and a further 12 still under investigation. Health officials say the outbreak is linked to a known strain of meningitis B, and current measures — including targeted vaccination and preventive antibiotics — appear to be helping limit further transmission.
Despite this, experts remain uncertain why the outbreak has grown so rapidly. Robin May described the situation as unusual, noting the high number of cases may be connected to a single event. He suggested this could be due either to specific behaviours among those affected or a possible increase in the bacteria’s ability to spread.
So far, around 600 meningitis B vaccines have been administered at the University of Kent in Canterbury, alongside more than 6,500 precautionary antibiotic doses given to students. Tragically, one university student and one school pupil have died in what officials have described as one of the fastest-growing outbreaks recorded.
Cases have also been identified at Canterbury Christ Church University and across several schools in the region. A related case has additionally been reported at a higher education institution in London, directly linked to the Kent cluster.
Meningitis is a serious infection affecting the protective membranes surrounding the brain and spinal cord. Meningitis B is caused by the Neisseria meningitidis bacterium, which can live harmlessly in the throat but may become life-threatening if it enters the bloodstream or spinal fluid. Rapid treatment with antibiotics is essential.
General practitioners across England have been advised to prescribe antibiotics to individuals who attended a Canterbury nightclub during early March, as well as students who recently left the University of Kent campus.
The UKHSA has issued a nationwide alert to NHS services outlining symptoms to watch for, while stressing there is currently no indication the outbreak will spread across the country.
Health officials continue to urge vigilance. The MenB vaccine offers protection against meningococcal B disease, but does not cover all strains or prevent transmission entirely. Individuals experiencing symptoms are strongly advised to seek immediate medical attention.
Authorities have also reassured the public that vaccine supplies remain sufficient, following reports of shortages in private pharmacies. All confirmed cases to date have been linked to Kent, as investigations continue.